Therapeutic microRNA Delivery Strategies with Special Emphasis on Cancer Therapy and Tumorigenesis: Current Trends and Future Challenges

被引:17
作者
Chakraborty, Chiranjib [1 ,2 ,3 ]
Wen, Zhi-Hong [2 ,3 ]
Agoramoorthy, Govindasamy [4 ]
Lin, Chan-Shing [2 ,3 ]
机构
[1] Galgotias Univ, Dept Bioinformat, Sch Comp & Informat Sci, Greater Noida, Uttar Pradesh, India
[2] Natl Sun Yat Sen Univ, Coll Marine Sci, Dept Marine Biotechnol & Resources, Kaohisung, Taiwan
[3] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Div Marine Biotechnol, Kaohisung, Taiwan
[4] Tajen Univ, Coll Pharm & Hlth Care, Pingtung 907, Taiwan
关键词
Biopharmaceutical industry; cancer therapy; miRNA delivery; therapeutic microRNA; tumorigenesis; SMALL INTERFERING RNAS; NUCLEIC-ACID; IN-VIVO; REPLACEMENT THERAPY; PANCREATIC-CANCER; TARGETED DELIVERY; CELL-PROLIFERATION; INSULIN-RESISTANCE; MEDIATED DELIVERY; PROSTATE-CANCER;
D O I
10.2174/1389200217666160126142408
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Over the decade, miRNAs are the most important molecules for the biopharmaceutical industry due to their relation with several human diseases. Presently, the phase-II clinical trial has been initiated for the first miRNA-based therapeutics ("Miravirsen") to treat HCV infection. It has been expected that many more miRNA-based therapeutics will enter the clinical trials. Therefore, it is important to develop different kinds of novel delivery systems with better efficacy and more efficiency, but fewer side effects. Methods: We have undertaken a structured search of bibliographic databases for peer-reviewed research literature to solve our review question. Literature survey was performed widely to write this review article. Results: In this review, we have discussed the various types of miRNA delivery systems such as viral vectors, lipid-based systems, nanocarriers, and LNA-customized DNA delivery without any delivery-mediated agent. Current status, technical support, and the future challenges for miRNA-based delivery are also discussed. Conclusion: Recent development and understanding of miRNA had shown the therapeutic potentiality of miRNA.
引用
收藏
页码:469 / 477
页数:9
相关论文
共 101 条
[71]   LNA-modified oligonucleotides mediate specific inhibition of microRNA function [J].
Orom, Ulf Andersson ;
Kauppinen, Sakari ;
Lund, Anders H. .
GENE, 2006, 372 :137-141
[72]   Lipid-based Nanoparticle Delivery of Pre-miR-107 Inhibits the Tumorigenicity of Head and Neck Squamous Cell Carcinoma [J].
Piao, Longzhu ;
Zhang, Manchao ;
Datta, Jharna ;
Xie, Xiujie ;
Su, Tizhi ;
Li, Hong ;
Teknos, Theodoros N. ;
Pan, Quintin .
MOLECULAR THERAPY, 2012, 20 (06) :1261-1269
[73]   Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice [J].
Pramanik, Dipankar ;
Campbell, Nathaniel R. ;
Karikari, Collins ;
Chivukula, Raghu ;
Kent, Oliver A. ;
Mendell, Joshua T. ;
Maitra, Anirban .
MOLECULAR CANCER THERAPEUTICS, 2011, 10 (08) :1470-1480
[74]   Co-delivery of as-miR-21 and 5-FU by Poly(amidoamine) Dendrimer Attenuates Human Glioma Cell Growth in Vitro [J].
Ren, Yu ;
Kang, Chun-Sheng ;
Yuan, Xu-bo ;
Zhou, Xuan ;
Xu, Peng ;
Han, Lei ;
Wang, Guang Xiu ;
Jia, Zhifan ;
Zhong, Yue ;
Yu, Shizhu ;
Sheng, Jing ;
Pu, Pei-yu .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2010, 21 (03) :303-314
[75]  
Robertson Barbara, 2010, Silence, V1, P10, DOI 10.1186/1758-907X-1-10
[76]   Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a [J].
Sakurai, Fuminori ;
Furukawa, Norihisa ;
Higuchi, Maiko ;
Okamoto, Sayuri ;
Ono, Kaori ;
Yoshida, Takeshi ;
Kondoh, Masuo ;
Yagi, Kiyohito ;
Sakamoto, Naoya ;
Katayama, Kazufumi ;
Mizuguchi, Hiroyuki .
VIRUS RESEARCH, 2012, 165 (02) :214-218
[77]   Lentivirus-mediated antagomir expression for specific inhibition of miRNA function [J].
Scherr, Michaela ;
Venturini, Letizia ;
Battmer, Karin ;
Schaller-Schoenitz, Michael ;
Schaefer, Daniel ;
Dallmann, Iris ;
Ganser, Arnold ;
Eder, Matthias .
NUCLEIC ACIDS RESEARCH, 2007, 35 (22)
[78]   Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b [J].
Scott, Gary K. ;
Goga, Andrei ;
Bhaumik, Dipa ;
Berger, Crystal E. ;
Sullivan, Christopher S. ;
Benz, Christopher C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (02) :1479-1486
[79]   Next Generation Delivery System for Proteins and Genes of Therapeutic Purpose: Why and How? [J].
Sharma, Ashish Ranjan ;
Kundu, Shyamal Kumar ;
Nam, Ju-Suk ;
Sharma, Garima ;
Doss, C. George Priya ;
Lee, Sang-Soo ;
Chakraborty, Chiranjib .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[80]   Regulation of microRNA function in somatic stem cell proliferation and differentiation [J].
Shenoy, Archana ;
Blelloch, Robert H. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (09) :565-576